UCLA Medical Center / David Geffen School of Medicine — Santa Monica, California

UCLA Medical Center / David Geffen School of Medicine is a clinical research site located in Santa Monica, California, United States 90404.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Medical Center / David Geffen School of Medicine has participated in 2 clinical trials.

Therapeutic areas: HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.

Sponsors: Seagen Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Santa Monica

Browse all research sites in California · View every site in Santa Monica

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Medical Center / David Geffen School of Medicine?

UCLA Medical Center / David Geffen School of Medicine has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Medical Center / David Geffen School of Medicine conducted?

UCLA Medical Center / David Geffen School of Medicine has 2 clinical trials on record. Their work covers HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.

Is UCLA Medical Center / David Geffen School of Medicine accredited by Crixeo Clinical Trials?

UCLA Medical Center / David Geffen School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Medical Center / David Geffen School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.